Targeting EPHA2 with Kinase Inhibitors in Colorectal Cancer
Abstract: The ephrin type‐A 2 receptor tyrosine kinase (EPHA2) is involved in the development and progression of various cancer types, including colorectal cancer (CRC). There is also evidence that EPHA2 plays a key role in the development of resistance to the endothelial growth factor receptor (EGFR) monoclonal antibody Cetuximab used clinically in CRC. Despite the promising pharmacological potential of EPHA2, only a handful of specific inhibitors are currently available. In this concept paper, general strategies for EPHA2 inhibition with molecules of low molecular weight (small molecules) are described. Furthermore, available examples of inhibiting EPHA2 in CRC using small molecules are summarized, highlighting the potential of this approach.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Targeting EPHA2 with Kinase Inhibitors in Colorectal Cancer ; day:05 ; month:10 ; year:2023 ; extent:7
ChemMedChem ; (05.10.2023) (gesamt 7)
- Creator
-
Tröster, Alix
Jores, Nathalie
Mineev, Konstantin S.
Sreeramulu, Sridhar
DiPrima, Michael
Tosato, Giovanna
Schwalbe, Harald
- DOI
-
10.1002/cmdc.202300420
- URN
-
urn:nbn:de:101:1-2023100515381510436918
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tröster, Alix
- Jores, Nathalie
- Mineev, Konstantin S.
- Sreeramulu, Sridhar
- DiPrima, Michael
- Tosato, Giovanna
- Schwalbe, Harald